More Business Wire
View Older Stories View Newer Stories-
RangeWater Teams Up with Revyse to Optimize Vendor Lifecycle Management Across 92,000 Units
-
CORRECTING and REPLACING ALLETE Board of Directors Declares Dividend on Common Stock
-
Pennsylvania American Water Awarded Two PENNVEST Loans to Expand Water Service in Washington County
-
Franklin Resources, Inc. Announces Third Quarter Results
-
Cheniere Partners Declares Quarterly Distributions
-
Corpay to Announce Second Quarter 2024 Results on August 7, 2024
-
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
-
CEL-SCI’s Phase 3 Population Analysis for Upcoming Confirmatory Registration Study in Head & Neck Cancer Demonstrates Well Balanced Patient Population, Confidence in Clinical Results
-
Ryde Takes Center Court with Tennis Star Sarah Pang Joining Ryde Empowers!
-
Premier Financial Corp. Announces Second Quarter 2024 Results and Strategic Merger with Wesbanco, Inc.
-
Orion S.A.’s 2023 Sustainability Report focuses on ‘driving innovation, enabling the everyday’
-
Casey's Announces Agreement to Acquire 198 CEFCO Convenience Stores
-
Fulcrum Lifting Opens New Columbus, Ohio Branch
-
Shift4 to Release Second Quarter Earnings Results on August 8, 2024
-
Free Financial Literacy Event Hosted by FICO Comes to Columbus in Partnership with Local Partners, the U.S. Soccer Foundation, and Chelsea FC During Pre-Season Summer Tour
-
Irenic Calls on Equity Commonwealth to Heed Shareholder Feedback and Pursue a Liquidation
-
New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
-
Concentra® to Announce Second Quarter 2024 Results on Thursday, August 1, 2024
-
Viant Announces Date of Second Quarter 2024 Financial Results and Conference Call
-
POTTERY BARN LAUNCHES COLLECTION INSPIRED BY THE NETFLIX SERIES “WEDNESDAY” IN COLLABORATION WITH AMAZON MGM STUDIOS CONSUMER PRODUCTS
-
Most Popular Best's Review’s Stories Include Secondary Perils and More
-
World Acceptance Corporation Reports Fiscal 2025 First Quarter Results
-
Generation Mining Provides Update on 2024 Summer Exploration Program
-
Boot Barn Holdings, Inc. to Report First Quarter Fiscal Year 2025 Results on August 7, 2024
-
Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS
-
U.S. Physical Therapy, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call
-
Dynacor Group Declares August 2024 Dividend
-
Element Solutions Inc to Participate in the KeyBanc Capital Markets’ Technology Leadership Forum
-
Paired Power Installs Resilient Off-Grid Solar Electric Vehicle Charger for Sonoco in South Carolina
-
Tikehau Capital: Disclosure of Shares Repurchases From 19 July 2024 to 25 July 2024
-
WisdomTree Announces Second Quarter 2024 Results
-
Newell Brands Announces Second Quarter 2024 Results
-
Stellar Bancorp, Inc. Reports Second Quarter 2024 Results
-
Virtus Investment Partners Announces Financial Results for Second Quarter 2024
-
Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu
-
Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024
-
ACCO Brands Corporation Declares Quarterly Dividend
-
Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology
-
Nexstar Media Group Declares Quarterly Cash Dividend of $1.69 Per Share, Announces New $1.5 Billion Share Repurchase Authorization
-
Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update
-
Super Group’s Betway Becomes Global Betting Partner of English Premier League Champions Manchester City
-
Bristol Myers Squibb Reports Second Quarter Financial Results for 2024
-
Colgate Announces 2nd Quarter 2024 Results
-
Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2024 and Raises Full Year Guidance
-
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma
-
Kontoor Brands Declares Quarterly Dividend
-
Booz Allen Hamilton Announces First Quarter Fiscal Year 2025 Results
-
Sonic Automotive Schedules Release of Second Quarter 2024 Financial Results
-
GrafTech Reports Second Quarter 2024 Results
-
Gorman-Rupp Reports Second Quarter 2024 Financial Results
